Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-23
DOI
10.3389/fimmu.2021.713779
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
- (2021) Fanny Onodi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Psoriasis
- (2021) Christopher E M Griffiths et al. LANCET
- Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis
- (2020) Kosuke Minaga et al. JOURNAL OF GASTROENTEROLOGY
- Gut microbiome alterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone
- (2020) K. Kamata et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease
- (2020) Kosuke Minaga et al. Scientific Reports
- Plasmacytoid Dendritic Cells: Development, Regulation, and Function
- (2019) Boris Reizis IMMUNITY
- Novel paradigms in systemic lupus erythematosus
- (2019) Thomas Dörner et al. LANCET
- Management strategies and future directions for systemic lupus erythematosus in adults
- (2019) Laura Durcan et al. LANCET
- Activated M2 macrophage contributes to the pathogenesis of IgG4‐related disease via TLR 7/ IL ‐33 signaling
- (2019) Noriko Ishiguro et al. Arthritis & Rheumatology
- Psoriasis biologics: a new era of choice
- (2019) Satveer K Mahil et al. LANCET
- Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis
- (2019) Yi-Ling Chen et al. Science Translational Medicine
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus
- (2018) Tatsuma Ban et al. INTERNATIONAL IMMUNOLOGY
- Do Type I Interferons Link Systemic Autoimmunities and Metabolic Syndrome in a Pathogenetic Continuum?
- (2018) Dipyaman Ganguly TRENDS IN IMMUNOLOGY
- Mechanistic Insights into Autoimmune Pancreatitis and IgG4-Related Disease
- (2018) Tomohiro Watanabe et al. TRENDS IN IMMUNOLOGY
- Detection of interferon alpha protein reveals differential levels and cellular sources in disease
- (2017) Mathieu P. Rodero et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-α and IL-33 Produced by Plasmacytoid Dendritic Cells
- (2017) Tomohiro Watanabe et al. JOURNAL OF IMMUNOLOGY
- Type I interferon–mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy
- (2017) Antonios Psarras et al. RHEUMATOLOGY
- Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
- (2017) Richard Furie et al. Arthritis & Rheumatology
- Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease
- (2017) Sachiko Furukawa et al. Scientific Reports
- Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
- (2016) Munther Khamashta et al. ANNALS OF THE RHEUMATIC DISEASES
- Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus
- (2016) Simone Caielli et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The association of novel IL-33 polymorphisms with sIL-33 and risk of systemic lupus erythematosus
- (2016) Jing Guo et al. MOLECULAR IMMUNOLOGY
- Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis
- (2016) T Watanabe et al. Mucosal Immunology
- Immunopathogenesis of pancreatitis
- (2016) T Watanabe et al. Mucosal Immunology
- Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease
- (2016) Christian Lood et al. NATURE MEDICINE
- Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease
- (2015) Sachiko Furukawa et al. CLINICAL IMMUNOLOGY
- Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
- (2015) Inna S. Afonina et al. IMMUNITY
- Plasmacytoid Dendritic Cell Activation and IFN-α Production Are Prominent Features of Murine Autoimmune Pancreatitis and Human IgG4-Related Autoimmune Pancreatitis
- (2015) Yasuyuki Arai et al. JOURNAL OF IMMUNOLOGY
- IgG4-related disease
- (2015) Terumi Kamisawa et al. LANCET
- Potential involvement of the IL-33–ST2 axis in the pathogenesis of primary Sjögren's syndrome
- (2014) Ahmad Awada et al. ANNALS OF THE RHEUMATIC DISEASES
- Specific roles for dendritic cell subsets during initiation and progression of psoriasis
- (2014) E. Glitzner et al. EMBO Molecular Medicine
- Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model
- (2014) Sarah L. Rowland et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus
- (2014) Vanja Sisirak et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of plasmacytoid dendritic cell subsets in allergic asthma
- (2013) H. Maazi et al. ALLERGY
- Recent advances in autoimmune pancreatitis: type 1 and type 2
- (2013) Terumi Kamisawa et al. GUT
- Anti-IFN- / Receptor Antibody Treatment Ameliorates Disease in Lupus-Predisposed Mice
- (2012) R. Baccala et al. JOURNAL OF IMMUNOLOGY
- Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes
- (2012) Julien Diana et al. NATURE MEDICINE
- IgG4-Related Disease
- (2012) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus
- (2011) G. S. Garcia-Romo et al. Science Translational Medicine
- The type I interferon system in the etiopathogenesis of autoimmune diseases
- (2011) Lars Rönnblom UPSALA JOURNAL OF MEDICAL SCIENCES
- Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease
- (2010) Arezou Khosroshahi et al. ARTHRITIS AND RHEUMATISM
- Intracellular Toll-like Receptors
- (2010) Amanda L. Blasius et al. IMMUNITY
- NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway
- (2010) Tomohiro Watanabe et al. JOURNAL OF CLINICAL INVESTIGATION
- Sequential Role of Plasmacytoid Dendritic Cells and Regulatory T Cells in Oral Tolerance
- (2009) Bertrand Dubois et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now